Lineage Cell Therapeutics (LCTX) Net Cash Flow (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Lineage Cell Therapeutics | 325.89 Mn | 261.99 Mn | 1.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,000.00% |
| Dec 31, 2025 | 109.31% |
| Sep 30, 2025 | 69.39% |
| Jun 30, 2025 | -384.33% |
| Mar 31, 2025 | -88.56% |
| Dec 31, 2024 | 1,047.58% |
| Sep 30, 2024 | 86.28% |
| Jun 30, 2024 | -269.07% |
| Mar 31, 2024 | 121.02% |
| Dec 31, 2023 | 276.00% |
| Sep 30, 2023 | -111.38% |
| Jun 30, 2023 | 342.51% |
| Mar 31, 2023 | 131.51% |
| Dec 31, 2022 | 70.76% |
| Sep 30, 2022 | -537.52% |
| Jun 30, 2022 | -131.85% |
| Mar 31, 2022 | 541.68% |
| Dec 31, 2021 | -323.14% |
| Sep 30, 2021 | -120.77% |
| Jun 30, 2021 | -75.59% |
| Mar 31, 2021 | 31,384.00% |
| Dec 31, 2020 | -99.62% |
| Sep 30, 2020 | 570.57% |
| Jun 30, 2020 | 1,248.18% |
| Mar 31, 2020 | 104.58% |
| Dec 31, 2019 | -178.55% |
| Sep 30, 2019 | 161.68% |
| Jun 30, 2019 | -72.23% |
| Mar 31, 2019 | -241.71% |
| Dec 31, 2018 | 155.51% |
| Sep 30, 2018 | -188.50% |
| Jun 30, 2018 | 66.12% |
| Mar 31, 2018 | -137.24% |
| Dec 31, 2017 | 782.76% |
| Sep 30, 2017 | 32.56% |
| Jun 30, 2017 | -336.86% |
| Mar 31, 2017 | 121.92% |
| Dec 31, 2016 | -397.56% |
| Sep 30, 2016 | 664.59% |
| Jun 30, 2016 | 102.43% |
| Mar 31, 2016 | -216.95% |
| Dec 31, 2015 | 635.57% |
| Sep 30, 2015 | -140.70% |
| Jun 30, 2015 | 258.81% |
| Mar 31, 2015 | -117.35% |
| Dec 31, 2014 | 362.70% |
| Sep 30, 2014 | -190.52% |
| Jun 30, 2014 | 632.26% |
| Mar 31, 2014 | 207.34% |
| Dec 31, 2013 | 84.82% |
| Sep 30, 2013 | -275.83% |
| Jun 30, 2013 | -21.64% |
| Mar 31, 2013 | 255.42% |
| Dec 31, 2012 | 25.55% |
| Sep 30, 2012 | -30.02% |
| Jun 30, 2012 | 36.87% |
| Mar 31, 2012 | -44.95% |
| Dec 31, 2011 | -400.82% |
| Sep 30, 2011 | 72.29% |
| Jun 30, 2011 | 9.53% |
| Mar 31, 2011 | -138.99% |
| Dec 31, 2010 | 11.60% |